Early-Life Risk for Pathological Anxiety

Tuesday, October 12, 2021, 2:00 pm EDT
Meet the Scientist - October 2021

Early-life anxiety is a risk factor for development of anxiety disorders, depression, and substance abuse. Research has revealed alterations in brain structure and function as well as underlying molecular factors that predispose individuals to develop pathological anxiety. This talk will discuss new treatment approaches that build on these findings, including efforts to increase the plasticity of specific brain circuits implicated in stress-related psychopathology.

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Ned H. Kalin, M.D.
Ned H. Kalin, M.D.
University of Wisconsin – Madison

Hedberg Professor and Chairman, Department of Psychiatry

Director, Health, Emotions Research Institute School of Medicine and Public Health

Scientific Council Member (Joined 2016)

Ned H. Kalin, M.D., is Chairman of the Department of Psychiatry at the University of Wisconsin-Madison, where he is the Director of the HealthEmotions Research Institute and Lane Neuroimaging Laboratory. He has made significant advances in uncovering basic brain and molecular mechanisms that cause children to be vulnerable to develop anxiety and depressive disorders. He serves as the principal investigator for several ongoing NIH funded research projects and has published widely on the adaptive and maladaptive expression of emotion and anxiety. He is Co-Editor of the Journal of Psychoneuroendocrinology. In addition to his research activities, he treats patients who suffer from anxiety and depression who are refractory to standard treatment.

Dr. Kalin is board certified by the American Board of Psychiatry and Neurology. He has been recognized for numerous awards including, most recently, being elected to the National Academy of Medicine and becoming a Distinguished Fellow of the American Psychiatric Association.

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy Award-nominated public television program “Healthy Minds,” and serves as host of the series. The program, which is broadcast nationwide, focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association and as an Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons.